Autophagy is a pathway of extreme importance in neurodegenerative disease and aging, as autophagy maintains normal cellular function by degrading aggregate-prone proteins and by supporting protein quality control. Reduced TOR signaling, imposed by rapamycin or dietary restriction, can delay neurological disease onset and ameliorate disease progression, suggesting shared pathways between aging and neurodegeneration. In organisms from yeast to mammals, reduced TOR signaling leads to increased autophagy and reduced protein translation. We, and others, have proposed that increased autophagy may be protective in aggregation-based neuronal diseases, but reduced translation may also be neuroprotective, as it has been shown to extend lifespan in worms and flies. However, other data suggests that maintenance of translation function at the level of S6 kinase is required for fully effective autophagy activation. Indeed, how these pathways are normally regulated, and dysregulated in situations of proteotoxic stress, remain to be established. In particular, the molecular basis of mTOR inhibition of autophagy is unknown, and the issue of cross-talk between the autophagy pathway and S6 kinase regulated protein translation is yet to be resolved. To study autophagy regulation in the nervous system, we developed a method for autophagy induction and monitoring in primary neurons. We have shown that expression of polyglutamine-expanded proteins produces caspase-mediated cell death in primary neurons, and that autophagy induction can protect against this misfolded protein stress. To begin to understand the basis of autophagy regulation in primary neurons, we performed microarray analysis of primary neurons induced to undergo autophagy, and have preliminarily validated gene expression alterations produced by nutrient deprivation. To understand the role of translational control in autophagy regulation and in neuroprotection, we have initiated studies of protein translation status in HD striatal-like cell lines as a prelude to translation state array analysis (TSAA) in these cell lines. Using a combination of in vitro and in vivo studies, we propose to examine the regulation of autophagy, the role of protein translation regulation in autophagy function, and the interaction of these two processes in neurodegenerative polyglutamine disease proteinopathies. In our first aim, we will complete gene expression, microRNA, and translational state array analysis (TSAA) of primary neurons induced to undergo autophagy, as we hypothesize that there must be transcriptional and/or translational regulation of autophagy in mammals, and we expect that such regulation is important for operation of the autophagy pathway in the CNS. In our second aim, we will determine the effect of reduced protein translation upon autophagy induction and neuroprotection in primary neurons, and will use TSAA to test if protein translation alterations occur in Huntington's (HD) disease. In our third aim, we will determine if reduced protein translation is beneficial, deleterious, or inconsequential in a polyglutamine proteinopathy, by crossing HD mice onto a reduced protein translation background, using two different models (S6K1 null and 4E-BP1 transgenic mice). Understanding the intersection of TOR signaling, autophagy pathway function, and protein synthesis regulation should provide crucial insights into normal neural function and neurological diseases caused by misfolded protein stress.
Protein misfolding is the basis of a number of common age-related neurological diseases, including Alzheimer's disease and Parkinson's disease. Nerve cells (neurons) are especially sensitive to toxicity caused by misfolded proteins. In this project, we examine two cellular processes that can mitigate misfolded protein toxicity in neurons, namely autophagy and protein translation. Autophagy is emerging as a crucial pathway in a variety of disease processes, ranging from cancer to neurodegeneration, yet very little is known about the transcriptional or translational regulation of the autophagy pathway. Furthermore, autophagy dysfunction likely plays a key role in the aging process. This work will integrate observations coming out of a variety of model organisms and experimental systems, and will determine their relevance to CNS function and their potential contribution to an important neurological disease, HD. Our results thus could have immediate application to therapy development in HD, as well as in AD, PD and other neurological proteinopathies, as autophagy induction strategies are currently being entertained as treatment options for these diseases. Activation of autophagy and reduction of protein translation can protect neurons from toxicity; therefore, we plan to determine how these processes are regulated in neurons, whether one process is regulated by the other, and how these processes affect neuron survival in the neurodegenerative disorder Huntington's disease - a model for misfolded protein toxicity. Another important aspect of this study is its focus upon TOR signaling pathway targets linked to neuroprotection and lifespan extension. One such target is the regulation of protein translation. Hence, this project will examine whether reduced protein synthesis is truly neuroprotective, and will attempt to uncover the regulatory interrelationships between protein translation state and autophagy pathway function.
|Dickey, Audrey S; Sanchez, Dafne N; Arreola, Martin et al. (2017) PPAR? activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis. Sci Transl Med 9:|
|Tsai, Shih-Yin; Rodriguez, Ariana A; Dastidar, Somasish G et al. (2016) Increased 4E-BP1 Expression Protects against Diet-Induced Obesity and Insulin Resistance in Male Mice. Cell Rep 16:1903-14|
|Dickey, Audrey S; Pineda, Victor V; Tsunemi, Taiji et al. (2016) PPAR-? is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically. Nat Med 22:37-45|
|Tsai, Shihyin; Sitzmann, Joanna M; Dastidar, Somasish G et al. (2015) Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity. J Clin Invest 125:2952-64|
|Cortes, Constanza J; La Spada, Albert R (2015) Autophagy in polyglutamine disease: Imposing order on disorder or contributing to the chaos? Mol Cell Neurosci 66:53-61|
|Dubinsky, Amy N; Dastidar, Somasish Ghosh; Hsu, Cynthia L et al. (2014) Let-7 coordinately suppresses components of the amino acid sensing pathway to repress mTORC1 and induce autophagy. Cell Metab 20:626-38|
|Cortes, Constanza J; La Spada, Albert R (2014) The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy. Drug Discov Today 19:963-71|
|McCormick, Mark A; Mason, Amanda G; Guyenet, Stephan J et al. (2014) The SAGA histone deubiquitinase module controls yeast replicative lifespan via Sir2 interaction. Cell Rep 8:477-86|
|Cortes, Constanza J; Miranda, Helen C; Frankowski, Harald et al. (2014) Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. Nat Neurosci 17:1180-9|
|Sekiyama, Kazunari; Waragai, Masaaki; Akatsu, Hiroyasu et al. (2014) Disease-Modifying Effect of Adiponectin in Model of ?-Synucleinopathies. Ann Clin Transl Neurol 1:479-489|
Showing the most recent 10 out of 18 publications